Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study

Prevalence ofN-Methyl-D-Aspartate Receptor Autoantibodies in the Peripheral Blood

(2014) Johann Steiner et al.   JAMA Psychiatry

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

(2013) Nuria Gresa-Arribas et al.   LANCET NEUROLOGY

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity

(2013) C Hammer et al.   MOLECULAR PSYCHIATRY

Psychiatric Manifestations of Anti-NMDA Receptor Encephalitis: Neurobiological Underpinnings and Differential Diagnostic Implications

(2013) Eleni Maneta et al.   PSYCHOSOMATICS

Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia

(2013) Johann Steiner et al.   JAMA Psychiatry

Serum IgG Antibodies Against the NR1Subunit of the NMDA Receptor Not Detected in Schizophrenia

(2012) Joseph C. Masdeu et al.   AMERICAN JOURNAL OF PSYCHIATRY

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features

(2012) Ko Tsutsui et al.   BMC Psychiatry

Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients

(2012) Ida S. Haussleiter et al.   SCHIZOPHRENIA RESEARCH

Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia

(2011) Jesse Rhoads et al.   SCHIZOPHRENIA RESEARCH

Disease-relevant autoantibodies in first episode schizophrenia

(2010) Michael S. Zandi et al.   JOURNAL OF NEUROLOGY

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

(2010) Josep Dalmau et al.   LANCET NEUROLOGY